Home/Filings/4/0001127602-25-008409
4//SEC Filing

PASCOE KEVIN CARLTON 4

Accession 0001127602-25-008409

CIK 0000877860other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:52 PM ET

Size

14.5 KB

Accession

0001127602-25-008409

Insider Transaction Report

Form 4
Period: 2025-03-03
PASCOE KEVIN CARLTON
Chief Investment Officer
Transactions
  • Award

    Common Stock

    2025-03-03+5,50061,330 total
  • Award

    Stock Option (Right to Buy) 2025

    2025-03-03+15,00015,000 total
    Exercise: $73.34From: 2025-03-03Exp: 2030-03-03Common Stock (15,000 underlying)
  • Award

    Stock Option (Right to Buy) 2025

    2025-03-03+15,00015,000 total
    Exercise: $73.34From: 2027-03-03Exp: 2030-03-03Common Stock (15,000 underlying)
  • Award

    Stock Option (Right to Buy) 2025

    2025-03-03+15,00015,000 total
    Exercise: $73.34From: 2026-03-03Exp: 2030-03-03Common Stock (15,000 underlying)
Holdings
  • Stock Option (Right to Buy) 2024

    Exercise: $57.76From: 2025-02-23Exp: 2029-02-23Common Stock (8,500 underlying)
    8,500
  • Stock Option (Right to Buy) 2023

    Exercise: $54.73From: 2025-02-24Exp: 2028-02-24Common Stock (8,500 underlying)
    8,500
  • Stock Option (Right to Buy) 2024

    Exercise: $57.76From: 2026-02-23Exp: 2029-02-23Common Stock (8,500 underlying)
    8,500
Footnotes (1)
  • [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting March 3, 2026

Issuer

NATIONAL HEALTH INVESTORS INC

CIK 0000877860

Entity typeother

Related Parties

1
  • filerCIK 0001630773

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:52 PM ET
Size
14.5 KB